Virtus Therapeutics Overview
- Status
-
Private
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$698K
- Investors
-
4
Virtus Therapeutics General Information
Description
Developer of small-molecule activators designed to treat rare genetic disorders like pantothenate kinase-associated neurodegeneration (PKAN). The company specializes in developing novel therapies for rare metabolic diseases, focusing on PKAN and propionic acidemia, utilizing techniques such as genomics, proteomics, and metabolomics, enabling healthcare providers to provide targeted treatment and improving patient outcomes.
Contact Information
Website
www.virtustherapeutics.comCorporate Office
- 100 York Street
- Apartment 4P
- New Haven, CT 06511-5652
- United States
Corporate Office
- 100 York Street
- Apartment 4P
- New Haven, CT 06511-5652
- United States
Virtus Therapeutics Timeline
Virtus Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Grant | 03-Oct-2023 | $698K | Completed | Startup | ||
| 4. Accelerator/Incubator | 01-Jan-2023 | Completed | Startup | |||
| 3. Accelerator/Incubator | 01-Jan-2021 | Completed | Startup | |||
| 2. Accelerator/Incubator | 01-Jan-2017 | $768K | $768K | Completed | Startup | |
| 1. University Spin-Out | 01-Jan-2020 | Completed | Startup |
Virtus Therapeutics Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| U.S. Department of Health and Human Services | Government | |||
| Accelerator for Biosciences in Connecticut | Accelerator/Incubator | |||
| Yale University | University | |||
| Yale Ventures | Accelerator/Incubator | Minority |
Virtus Therapeutics FAQs
-
Where is Virtus Therapeutics headquartered?
Virtus Therapeutics is headquartered in New Haven, CT.
-
What industry is Virtus Therapeutics in?
Virtus Therapeutics’s primary industry is Drug Discovery.
-
Is Virtus Therapeutics a private or public company?
Virtus Therapeutics is a Private company.
-
What is Virtus Therapeutics’s current revenue?
The current revenue for Virtus Therapeutics is .
-
How much funding has Virtus Therapeutics raised over time?
Virtus Therapeutics has raised $1.07M.
-
Who are Virtus Therapeutics’s investors?
U.S. Department of Health and Human Services, Accelerator for Biosciences in Connecticut, Yale University, and Yale Ventures have invested in Virtus Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process